Article
Development of linezolid and daptomycin resistance in vancomycin resistant Enterococcus faecium during antibiotic treatment.
FEMS microbiology letters - 7 Jan 2026
Grim Simone Rønager, Worning Peder, Gburi Farah Hammadi Batti, Hammerum Anette, Bartels Mette Damkjær, Søes Lillian Marie
Abstract excerpt
The increasing incidence of vancomycin-resistant enterococci (VRE) over the past decade has reduced treatment options largely to linezolid and daptomycin. However, the emergence of resistance to both agents further complicates the management of VRE infections. While the mechanisms of linezolid resistance are relatively well understood, those underlying daptomycin resistance remain less clearly defined. In this...
Read the complete abstract on PubMedTopics
- Daptomycin
- Anti-Bacterial Agents
- Enterococcus faecium
- Linezolid
- Humans
- Microbial Sensitivity Tests